U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 17

1.

RNA sequencing of Bifidobacterium longum subsp. longum SC596 in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. longum SC596 to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium longum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL22529
18 Samples
Download data: TXT
Series
Accession:
GSE87697
ID:
200087697
2.

RNA sequencing of Bifidobacterium bifidum SC555 in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium bifidum SC555 to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium bifidum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18891
20 Samples
Download data: TXT
Series
Accession:
GSE59053
ID:
200059053
3.

RNA sequencing of Bifidobacterium longum subsp. infantis in response to various substrates

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. Infantis to pooled and individual human milk oligosaccharides (HMO) relative to lactose
Organism:
Bifidobacterium longum subsp. infantis ATCC 15697 = JCM 1222 = DSM 20088
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18859
18 Samples
Download data: TXT
Series
Accession:
GSE58773
ID:
200058773
4.

Human Milk Oligosaccharide Utilization in Intestinal Bifidobacteria is Governed by Global Transcriptional Regulator NagR

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) is a prevalent beneficial bacterium that colonizes the human neonatal gut and is uniquely adapted to efficiently use human milk oligosaccharides (HMOs) as a carbon and energy source. Multiple studies have focused on characterizing the elements of HMO utilization machinery in B. infantis; however, the regulatory mechanisms governing the expression of these catabolic pathways remain poorly understood. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
12 Samples
Download data: TXT
Series
Accession:
GSE196064
ID:
200196064
5.

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697

(Submitter supplied) Human milk oligosaccharides (HMOs) function as prebiotics for beneficial bacteria in the developing gut, often dominated by Bifidobacterium spp. To understand the relationship between Bifidobacterium utilizing HMOs and how the metabolites that are produced could affect the host, we analyzed the metabolism of HMO 2’-fucosyllactose (2’-FL), 3-fucosyllactose (3FL and difucosyllactose (DFL) in Bifidobacterium longum ssp. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL25787
41 Samples
Download data: TSV
Series
Accession:
GSE151933
ID:
200151933
6.

RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides.

(Submitter supplied) Background: Breastfed human infants are predominantly colonized by bifidobacteria that thrive on human milk oligosaccharides (HMO). The two most predominant species of bifidobacteria in infant feces are Bifidobacterium breve (B. breve) and Bifidobacterium longum subsp. infantis (B. infantis), both avid HMO-consumer strains. Our laboratory has previously shown that B. infantis, when grown on HMO, increase adhesion to intestinal cells and increase the expression of the anti-inflammatory cytokine interleukin-10. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
9 Samples
Download data: XLSX
7.

RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides.

(Submitter supplied) Background: Breastfed human infants are predominantly colonized by bifidobacteria that thrive on human milk oligosaccharides (HMO). The two most predominant species of bifidobacteria in infant feces are Bifidobacterium breve (B. breve) and Bifidobacterium longum subsp. infantis (B. infantis), both avid HMO-consumer strains. Our laboratory has previously shown that B. infantis, when grown on HMO, increase adhesion to intestinal cells and increase the expression of the anti-inflammatory cytokine interleukin-10. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
9 Samples
Download data: XLSX
8.

Novel Genes and Metabolite Trends in Bifidobacterium longum ssp. infantis Bi-26 Involved in Metabolism of Human Milk Oligosaccharide 2’-fucosyllactose

(Submitter supplied) Human milk oligosaccharides (HMOs) function as prebiotics for beneficial bacteria in the developing gut, often dominated by Bifidobacterium spp. To understand the relationship between Bifidobacterium utilizing HMOs and how the metabolites that are produced could affect the host, we analyzed the metabolism of HMO 2’-fucosyllactose (2’-FL) in Bifidobacterium longum ssp. infantis Bi-26. RNA-seq and metabolite analysis (NMR/GCMS) was performed on samples at early (A600=0.25), mid-log (0.5-0.7) and late-log phases (1.0-2.0) of growth. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL25787
12 Samples
Download data: GFF, TSV
Series
Accession:
GSE122350
ID:
200122350
9.

Bifidobacterium infantis intracellular 2-oxogluturate concentration is inversely related to nitrogen accessibility

(Submitter supplied) Bifidobacterium longum subsp. infantis (B. infantis) resides in the human infant gut and helps with the utilization of human milk-derived nutrient components. While its utilization of various carbohydrate sources has been studied extensively, mechanisms behind utilization of nitrogen components from human milk remain largely unknown. In this study, we present B. infantis growth profiles on the N-containing human milk oligosaccharides (HMO) as nitrogen sources, namely, lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT). more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
14 Samples
Download data: CSV, TXT
Series
Accession:
GSE209665
ID:
200209665
10.

Bifidobacterium longum subsp. infantis transcriptomes in response to various nitrogen sources

(Submitter supplied) The purpose of this project was to determine the whole transcriptome response of Bifidobacterium longum subsp. infantis to human milk urea compared to complex nitrogen and L-cysteine.
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
18 Samples
Download data: TXT
Series
Accession:
GSE155078
ID:
200155078
11.

Bifidobacterium breve UCC2003 metabolizes lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways

(Submitter supplied) Recent studies have begun to elucidate the mechanisms of utilisation of some human milk oligosaccharides (HMO) components by Bifidobacterium breve. However, this phenomenon is still relatively poorly understood, with little to no work to date in understanding a number of specific structures common to HMO.   In this study, we demonstrate that the prototype B. breve strain UCC2003 possesses specific metabolic pathways for the utilisation of Lacto-N-Tetraose and Lacto-N-neoTetraose, which represent the central moieties of Type I and Type II HMOs, respectively. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platform:
GPL13210
10 Samples
Download data: TXT
Series
Accession:
GSE84710
ID:
200084710
12.

Bifidobacterium infantis metabolizes 2´fucosyllactose-derived and free fucose through a common catabolic pathway resulting in 1,2-propanediol secretion

(Submitter supplied) Human milk oligosaccharides (HMOs) enrich beneficial bifidobacteria in the infant gut microbiome which produce molecules that impact development and physiology. 2´fucosyllactose (2´FL) is a highly abundant fucosylated HMO which is utilized by Bifidobacterium longum subsp. infantis, despite limited scientific understanding of the underlying mechanism. Moreover, there is not a current consensus on whether free fucose could be metabolized when not incorporated in a larger oligosaccharide structure. more...
Organism:
Bifidobacterium longum subsp. infantis
Type:
Expression profiling by high throughput sequencing
Platform:
GPL28926
6 Samples
Download data: CSV, TXT
Series
Accession:
GSE159189
ID:
200159189
13.

In vitro transcriptional profiling of Bacteroides fragilis in glucose and human milk oligosaccharides

(Submitter supplied) The factors that govern the retention and abundance of specific microbial lineages within a developing intestinal microbiota remain poorly defined. Human milk oligosaccharides consumed by nursing infnats pass undigested to the distal gut where they may be consumed by microbes. We investigated the transcriptional response of Bacterides fragilis, a prominent gut resident, to the presence of HMOs.
Organism:
Bacteroides fragilis NCTC 9343
Type:
Expression profiling by array
Platform:
GPL14584
4 Samples
Download data: CEL
Series
Accession:
GSE32207
ID:
200032207
14.

In vitro transcriptional profiling of Bacteroides thetaiotaomicron in lactose, galactose and human milk oligosaccharides

(Submitter supplied) Investigation of the overall in vitro response of Bacteroides thetaiotaomicron to human milk oligosaccharides. Comparison with response to MM-lactose and MM-galactose (Analysis performed using as a baseline datasets GSM301635 and GSM301637 corresponding to Bacteroides thetaiotaomicron response in MM-Glucose)
Organism:
Bacteroides thetaiotaomicron; Bifidobacterium longum
Type:
Expression profiling by array; Third-party reanalysis
Platform:
GPL1821
8 Samples
Download data: CEL, TXT
Series
Accession:
GSE26772
ID:
200026772
15.

Bifidobacterium breve UCC2003 employs multiple transcriptional regulators in a series of glycan-induced positive feedback loops to regulate HMO metabolism

(Submitter supplied) Regulation of carbohydrate metabolism in Bifidobacterium breve has been studied in detail for a variety of both plant and human-derived glycans, particularly in the model strain UCC2003. We have recently comprehensively elucidated the precise metabolic pathways by which the human milk oligosaccharide (HMO) components LNT, LNnT and LNB are utilized by B. breve UCC2003. However, no work has been carried out to date in identifying and understanding the regulatory mechanisms that control transcription of the genetic loci involved in these metabolic pathways. more...
Organism:
Bifidobacterium breve UCC2003
Type:
Expression profiling by array
Platforms:
GPL24137 GPL24138
8 Samples
Download data: TXT
Series
Accession:
GSE105108
ID:
200105108
16.

Next generation sequencing based transcriptomic analysis of oxidative stress response in Bifidobacterium longum BBMN68

(Submitter supplied) Bifidobacterium longum strain BBMN68 is resistant to low concentrations of oxygen. In this study, a transcriptomic study was performed to detail the cellular response of B. longum strain BBMN68 to oxidative stress. Oxygen and its intermediate metabolites, reactive oxygen species (ROS), induced abundant changes in gene expression at the mRNA level. Increased expression was found for genes involved in ROS detoxification and the redox homeostasis system, protein and DNA synthesis and repair, the Fe–S cluster assembly system, and biosynthesis of branched-chain amino acids and tetrahydrofolate. more...
Organism:
Bifidobacterium longum
Type:
Expression profiling by high throughput sequencing
Platform:
GPL17084
3 Samples
Download data: TXT
Series
Accession:
GSE65320
ID:
200065320
17.

Bifidobacterium kashiwanohense expresses fucosidases necessary for fucosyllactose utilisation as an adaptation to the infant gut environment

(Submitter supplied) Bifidobacteria dominate the composition of the neonatal gut microbiota in the first number of weeks following birth. A number of species in particular are found with a significantly higher frequency in the microbiome of breastfed infants, owing to their ability to rely on Human Milk Oligosacchraides (HMOs) as their sole carbohydrate substrate; namely B. bifidum, B. longum spp. infantis and B. breve. more...
Organism:
Bifidobacterium breve UCC2003; Bifidobacterium catenulatum subsp. kashiwanohense
Type:
Expression profiling by array
Platforms:
GPL24138 GPL24316
10 Samples
Download data: TXT
Series
Accession:
GSE107439
ID:
200107439
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=10|blobid=MCID_677e8e5a0bdf8a6e73648f7a|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center